Persistence of Bactericidal Activity at 4 Years After 2 Primary Doses of a Recombinant, 4-Component, Meningococcal Serogroup B Vaccine (4CMenB) and Response to a Booster Dose in Ad...

por Nolan, Terry, Garfield, Hartley, Gupta, Anil, Ferguson, Murdo, Marshall, Helen, D’Agostino, Diego, Toneatto, Daniela
Publicado 2017

1083 Comparative Evaluation of Two Different Investigational Meningococcal ABCWY Vaccine Formulations in Adolescents and Young Adults

por Block, Stan L., Szenborn, Leszek, Daly, Wendy, Jackowska, Teresa, Narasimhan, Vas, D'Agostino, Diego, Han, Linda, Dull, Peter M, Smolenov, Igor
Publicado 2014

Continuing trastuzumab beyond disease progression: outcomes analysis in patients with metastatic breast cancer

por Cancello, Giuseppe, Montagna, Emilia, D'Agostino, Diego, Giuliano, Mario, Giordano, Antonio, Di Lorenzo, Giuseppe, Plaitano, Monica, De Placido, Sabino, De Laurentiis, Michele
Publicado 2008

152. Protective Antibody Levels 7.5 Years After Primary Vaccination in Adolescence With a Recombinant, 4-Component, Meningococcal Serogroup B Vaccine (4CMenB) and Response to a Boo...

por Nolan, Terry, O’Ryan, Miguel, Santolaya, María Elena, De Looze, Ferdinandus, Marshall, Helen, Richmond, Peter, Henein, Sam, Rheault, Paul, Heaton, Ken, Perrett, Kirsten, Garfield, Hartley, Gupta, Anil, Ferguson, Murdo, D’Agostino, Diego, Toneatto, Daniela
Publicado 2018